Interstitial Lung Diseases (ILDs) for PLAB 1
Interstitial Lung Diseases (ILDs) represent a diverse group of lung disorders characterized by inflammation and scarring (fibrosis) of the interstitium, the tissue and space around the air sacs (alveoli) in your lungs. This damage makes it harder for your lungs to transfer oxygen into your bloodstream. Understanding ILDs is crucial for PLAB 1 as they can present with varied symptoms and require careful diagnosis and management.
Key Characteristics of ILDs
Common Types of Interstitial Lung Diseases
ILDs can be broadly categorized based on their cause or specific pathological features. Some are idiopathic (no known cause), while others are linked to specific exposures or systemic diseases.
| Category | Examples | Key Features |
|---|---|---|
| Idiopathic Interstitial Pneumonias (IIPs) | Idiopathic Pulmonary Fibrosis (IPF), Nonspecific Interstitial Pneumonia (NSIP) | Progressive fibrosis, often without a clear external cause. |
| Connective Tissue Disease-Associated ILDs | Rheumatoid Arthritis-ILD, Scleroderma-ILD, Lupus-ILD | ILD occurring in patients with autoimmune diseases. |
| Environmental/Occupational ILDs | Hypersensitivity Pneumonitis (HP), Asbestosis, Silicosis | Caused by inhalation of organic dusts (e.g., mold, bird droppings) or inorganic dusts (e.g., asbestos, silica). |
| Drug-Induced ILDs | Amiodarone, Methotrexate, Nitrofurantoin | Lung damage resulting from certain medications. |
Focus on Idiopathic Pulmonary Fibrosis (IPF)
IPF is the most common and often the most aggressive form of IIP. It's characterized by a progressive and irreversible scarring of the lungs, leading to significant respiratory impairment.
Diagnosis and Investigation
Diagnosing ILDs requires a systematic approach, often involving a multidisciplinary team.
The diagnostic pathway for ILDs typically begins with a thorough patient history, focusing on symptoms like dyspnea and cough, as well as occupational and environmental exposures, and family history. Physical examination may reveal characteristic 'Velcro' crackles on auscultation, indicating fibrosis.
Key Investigations:
- High-Resolution Computed Tomography (HRCT) of the Chest: This is the cornerstone of ILD imaging, providing detailed views of the lung parenchyma. Specific patterns like Usual Interstitial Pneumonia (UIP), Nonspecific Interstitial Pneumonia (NSIP), and organizing pneumonia are identified.
- Pulmonary Function Tests (PFTs): These assess lung volumes and gas exchange, typically showing a restrictive pattern (reduced lung volumes) and impaired diffusion capacity (DLCO).
- Arterial Blood Gases (ABGs): To assess oxygenation and ventilation status.
- Bronchoscopy with Bronchoalveolar Lavage (BAL): Can help identify infections or inflammatory cells, particularly useful in certain ILD subtypes.
- Surgical Lung Biopsy: May be required in ambiguous cases to confirm the diagnosis and specific histological pattern, especially for differentiating between different IIPs.
Text-based content
Library pages focus on text content
Management Principles
Management strategies for ILDs are tailored to the specific type, severity, and progression of the disease. The primary goals are to slow disease progression, alleviate symptoms, and improve quality of life.
For IPF, antifibrotic medications like pirfenidone and nintedanib are now standard of care to slow disease progression. For other ILDs, treatment may involve immunosuppressants (e.g., corticosteroids, azathioprine) if an inflammatory or autoimmune component is suspected.
Other important aspects of management include pulmonary rehabilitation, oxygen therapy for hypoxemia, and vaccination against influenza and pneumococcal disease. Lung transplantation is an option for select patients with severe, progressive disease.
Inflammation and scarring (fibrosis) of the lung interstitium.
Idiopathic Pulmonary Fibrosis (IPF).
High-Resolution Computed Tomography (HRCT) of the chest.
Learning Resources
Provides a clear overview of ILDs, their causes, symptoms, diagnosis, and treatment options from a UK healthcare perspective.
Offers comprehensive information on IPF, including patient stories, symptom management, and treatment advancements.
A detailed explanation of ILDs, covering causes, risk factors, symptoms, diagnosis, and treatment from a leading medical institution.
A professional medical resource offering in-depth information on the pathophysiology, diagnosis, and management of ILDs, suitable for healthcare professionals.
Patient-focused information from the American Thoracic Society, explaining ILDs in an accessible manner.
A highly respected clinical resource providing detailed, evidence-based information on ILDs, often used by medical professionals for reference.
A concise video explaining what ILDs are, their causes, and how they affect the lungs.
A visual guide to the characteristic patterns seen on HRCT scans for various ILDs, crucial for radiological interpretation.
Dedicated to advancing the understanding, treatment, and cure of pulmonary fibrosis, offering resources for patients and caregivers.
A hypothetical forum discussion thread where PLAB aspirants discuss common ILD questions and key knowledge points relevant to the exam. (Note: Specific URL is illustrative; actual forums may vary.)